Physician dispensed skincare products, also known as medical skincare products, are skincare products made from natural ingredients and do not contain any additives such as pigments, fragrances, preservatives, etc. that can easily cause skin sensitivity. It is not a drug, but it can serve as an adjuvant therapy for some skin diseases that cause damage.

Overview of Market Development

In recent years, driven by the increase in consumer health awareness and specific skincare needs, the global physician dispensed skincare product market has continued to expand. According to our research data, the estimated global physician dispensed skincare product market size in 2024 is $15.16 billion, an increase of 9.76% compared to 2023.

In the coming years, with the increasing attention of consumers to skin health issues, the deepening of technological research and development, and further policy support, it is expected that this market will continue to maintain its growth trend. By 2029, the global physician dispensed skincare product market size is expected to increase to $19.87 billion. The CAGR for 2024-2029 is estimated to be 5.57%.

Segmented Market Analysis

From the perspective of Zen forest types, based on their functions and usage areas, physician dispensed skincare products can be divided into two categories: skin care products and eye care products. Among them, skin care products dominate the market, with an expected market share of 77.69% by 2024.

From the perspective of sales channels, doctors mainly distribute skincare products through hospital pharmacies, retail pharmacies, and online channels. Among them, hospital pharmacies occupy the highest share, estimated at 40.23% in 2024.

Source: www.globalmarketmonitor.com

Analysis of Market Competition Pattern

From the perspective of market competition, the concentration of the global physician dispensed skincare product market is moderate. Data shows that in 2023, the total revenue of the top 3 companies in the physician distribution skincare market was $5352 million, with a total revenue share of 38.76%. The top 3 companies were L'Or é al, Johnson and Johnson, and Bausch Health. In 2023, these three companies' revenue from physician dispensed skincare products accounted for 23.01%, 10.02%, and 5.73% of the global market, respectively.

Companies	Market Revenue (Million USD)	Market Share
L'Oréal	3177	23.01%
Johnson and Johnson	1384	10.02%
Bausch Health	791	5.73%
Top3 Companies	5352	38.76%